Summary

Global Immunoprotein Diagnostic Testing Market is valued at approximately USD 8.91 billion in 2023 and is anticipated to grow with a robust CAGR of 7.73% over the forecast period from 2024 to 2032. Immunoprotein diagnostic testing, which focuses on the identification and quantification of immunoproteins, plays a critical role in diagnosing a spectrum of immune-related disorders, including autoimmune diseases, infectious diseases, and certain cancers. The escalating prevalence of chronic diseases, alongside significant advancements in diagnostic technologies, has propelled the market forward. Immunoproteins, such as immunoglobulins, complement proteins, and C-reactive proteins, are essential markers in these diagnostic procedures, offering vital insights into immune responses.

The market's trajectory is predominantly influenced by the growing incidence of chronic and autoimmune conditions, including cancer, rheumatoid arthritis, and cardiovascular diseases, which demand precise diagnostic tests. An aging global population, more susceptible to these ailments, further accelerates market growth. Technological innovations, particularly in automated and high-sensitivity assays, have enhanced the accuracy and efficiency of immunoprotein diagnostic tests, fostering widespread adoption. However, the high costs associated with these advanced diagnostic technologies, coupled with limited awareness in developing regions, are significant challenges that could impede market expansion. On the other hand, the market is poised to benefit from the rising demand for personalized medicine, which depends on accurate diagnostic tools, and the ongoing expansion of healthcare infrastructure in emerging economies.

Regionally, North America stands as the dominant player in the Immunoprotein Diagnostic Testing market, benefiting from its advanced healthcare infrastructure, substantial healthcare expenditure, and the presence of leading industry players. The region’s focus on early diagnosis and effective management of chronic diseases underscores its leading position. Europe trails closely behind, driven by similar factors and robust governmental support for healthcare initiatives. Meanwhile, the Asia-Pacific region is projected to experience the most rapid growth during the forecast period, spurred by increasing rates of chronic diseases, heightened healthcare awareness, and swift advancements in healthcare infrastructure, particularly in rapidly developing nations such as China and India.

Major market players included in this report are:
Agilent Technologies, Inc.
Danaher Corporation
Thermo Fisher Scientific Inc.
PerkinElmer Inc.
Bio-Rad Laboratories, Inc.
Aurora Biomed Inc.
Tecan Trading AG
Promega Corporation
Charles River Laboratories
Creative Biolabs
The detailed segments and sub-segments of the market are explained below:
By Test:
• Complement System Proteins Diagnostic Tests
• Free Light Chain Diagnostic Tests
• Haptoglobin Diagnostic Tests
• Immunoglobulin Diagnostic Tests
• Prealbumin Diagnostic Tests
• C-Reactive Protein (CRP) Diagnostic Tests
By Application:
• Infectious Disease Testing
• Oncology Testing
• Endocrine Testing
• Toxicology Testing
• Allergy Testing
• Autoimmune Disease Testing
By Technology:
• Radioimmunoassay
• Enzyme Based Immunoassay
• Chemiluminescence Assay
• Immunofluorescence Assay
• Immunoturbidity Assay
• Immunoprotein Electrophoresis
By End Use:
• Hospitals and Clinics
• Diagnostic Laboratories
• Others
By Distribution Channel:
• Direct Tender
• Retail Sales
By Region:
North America
• U.S.
• Canada
Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
Latin America
• Brazil
• Mexico
• RoLA
Middle East & Africa
• Saudi Arabia
• South Africa
• RoMEA
Years considered for the study are as follows:
• Historical year – 2022
• Base year – 2023
• Forecast period – 2024 to 2032
Key Takeaways:
• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market

ページTOPに戻る

Table of Contents

Chapter 1. Global Immunoprotein Diagnostic Testing Market Executive Summary
1.1. Global Immunoprotein Diagnostic Testing Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Test
1.3.2. By Application
1.3.3. By Technology
1.3.4. By End Use
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Immunoprotein Diagnostic Testing Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

Chapter 3. Global Immunoprotein Diagnostic Testing Market Dynamics
3.1. Market Drivers
3.1.1. Growing prevalence of chronic diseases
3.1.2. Technological advancements in diagnostic methods
3.1.3. Increasing aging population
3.2. Market Challenges
3.2.1. High costs of advanced diagnostic technologies
3.2.2. Lack of awareness in developing regions
3.3. Market Opportunities
3.3.1. Rising demand for personalized medicine
3.3.2. Expansion of healthcare infrastructure in emerging economies
3.3.3. Adoption of automated and high-sensitivity assays

Chapter 4. Global Immunoprotein Diagnostic Testing Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Immunoprotein Diagnostic Testing Market Size & Forecasts by Test 2022-2032
5.1. Segment Dashboard
5.2. Global Immunoprotein Diagnostic Testing Market: Test Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Complement System Proteins Diagnostic Tests
5.2.2. Free Light Chain Diagnostic Tests
5.2.3. Haptoglobin Diagnostic Tests
5.2.4. Immunoglobulin Diagnostic Tests
5.2.5. Prealbumin Diagnostic Tests
5.2.6. C-Reactive Protein (CRP) Diagnostic Tests

Chapter 6. Global Immunoprotein Diagnostic Testing Market Size & Forecasts by Application 2022-2032
6.1. Segment Dashboard
6.2. Global Immunoprotein Diagnostic Testing Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Infectious Disease Testing
6.2.2. Oncology Testing
6.2.3. Endocrine Testing
6.2.4. Toxicology Testing
6.2.5. Allergy Testing
6.2.6. Autoimmune Disease Testing

Chapter 7. Global Immunoprotein Diagnostic Testing Market Size & Forecasts by Technology 2022-2032
7.1. Segment Dashboard
7.2. Global Immunoprotein Diagnostic Testing Market: Technology Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Radioimmunoassay
7.2.2. Enzyme Based Immunoassay
7.2.3. Chemiluminescence Assay
7.2.4. Immunofluorescence Assay
7.2.5. Immunoturbidity Assay
7.2.6. Immunoprotein Electrophoresis

Chapter 8. Global Immunoprotein Diagnostic Testing Market Size & Forecasts by End Use 2022-2032
8.1. Segment Dashboard
8.2. Global Immunoprotein Diagnostic Testing Market: End Use Revenue Trend Analysis, 2022 & 2032 (USD Billion)
8.2.1. Hospitals and Clinics
8.2.2. Diagnostic Laboratories
8.2.3. Others

Chapter 9. Global Immunoprotein Diagnostic Testing Market Size & Forecasts by Distribution Channel 2022-2032
9.1. Segment Dashboard
9.2. Global Immunoprotein Diagnostic Testing Market: Distribution Channel Revenue Trend Analysis, 2022 & 2032 (USD Billion)
9.2.1. Direct Tender
9.2.2. Retail Sales

Chapter 10. Global Immunoprotein Diagnostic Testing Market Size & Forecasts by Region 2022-2032
10.1. North America Immunoprotein Diagnostic Testing Market
10.1.1. U.S. Immunoprotein Diagnostic Testing Market
10.1.1.1. Test breakdown size & forecasts, 2022-2032
10.1.1.2. Application breakdown size & forecasts, 2022-2032
10.1.2. Canada Immunoprotein Diagnostic Testing Market
10.2. Europe Immunoprotein Diagnostic Testing Market
10.2.1. U.K. Immunoprotein Diagnostic Testing Market
10.2.2. Germany Immunoprotein Diagnostic Testing Market
10.2.3. France Immunoprotein Diagnostic Testing Market
10.2.4. Spain Immunoprotein Diagnostic Testing Market
10.2.5. Italy Immunoprotein Diagnostic Testing Market
10.2.6. Rest of Europe Immunoprotein Diagnostic Testing Market
10.3. Asia-Pacific Immunoprotein Diagnostic Testing Market
10.3.1. China Immunoprotein Diagnostic Testing Market
10.3.2. India Immunoprotein Diagnostic Testing Market
10.3.3. Japan Immunoprotein Diagnostic Testing Market
10.3.4. Australia Immunoprotein Diagnostic Testing Market
10.3.5. South Korea Immunoprotein Diagnostic Testing Market
10.3.6. Rest of Asia Pacific Immunoprotein Diagnostic Testing Market
10.4. Latin America Immunoprotein Diagnostic Testing Market
10.4.1. Brazil Immunoprotein Diagnostic Testing Market
10.4.2. Mexico Immunoprotein Diagnostic Testing Market
10.4.3. Rest of Latin America Immunoprotein Diagnostic Testing Market
10.5. Middle East & Africa Immunoprotein Diagnostic Testing Market
10.5.1. Saudi Arabia Immunoprotein Diagnostic Testing Market
10.5.2. South Africa Immunoprotein Diagnostic Testing Market
10.5.3. Rest of Middle East & Africa Immunoprotein Diagnostic Testing Market

Chapter 11. Competitive Intelligence
11.1. Key Company SWOT Analysis
11.1.1. Agilent Technologies, Inc.
11.1.2. Danaher Corporation
11.1.3. Thermo Fisher Scientific Inc.
11.2. Top Market Strategies
11.3. Company Profiles
11.3.1. Agilent Technologies, Inc.
11.3.1.1. Key Information
11.3.1.2. Overview
11.3.1.3. Financial (Subject to Data Availability)
11.3.1.4. Product Summary
11.3.1.5. Market Strategies
11.3.2. Danaher Corporation
11.3.3. Thermo Fisher Scientific Inc.
11.3.4. PerkinElmer Inc.
11.3.5. Bio-Rad Laboratories, Inc.
11.3.6. Aurora Biomed Inc.
11.3.7. Tecan Trading AG
11.3.8. Promega Corporation
11.3.9. Charles River Laboratories
11.3.10. Creative Biolabs

Chapter 12. Research Process
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes